The Parathyroid Gland and Heart Disease
References
- Shoback D , Sellmeyer D , Bikle DD. Metabolic bone disease. In: Gardner DG , Shoback D , editors. Greenspan's basic & clinical endocrinology. 9th ed. New York, NY: The McGraw-Hill Companies; 2011. p. 227– 284.
- Pyram R , Mahajan G , Gliwa A. Primary hyperparathyroidism: Skeletal and non-skeletal effects, diagnosis and management. Maturitas. 2011 Nov; 70 3: 246– 55.
- Schlüter KD Piper HM. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc Res. 1998 Jan; 37 1: 34– 41.
- Schlüter KD. PTH and PTHrP: Similar Structures but Different Functions. News Physiol Sci. 1999 Dec; 14: 243– 9.
- Andersson P , Rydberg E , Willenheimer R. Primary hyperparathyroidism and heart disease--a review. Eur Heart J. 2004 Oct; 25 20: 1776– 87.
- Yao L , Folsom AR , Pankow JS , Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study. J Hypertens. 2016 Feb; 34 2: 196– 203.
- Vlachakis ND , Frederics R , Valasquez M , Alexander N , Singer F , Maronde RF. Sympathetic system function and vascular reactivity in hypercalcemic patients. Hypertension. 1982 May–Jun; 4 3: 452– 8.
- Brown J , de Boer IH , Robinson-Cohen C , Aldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosis. J Clin Endocrinol Metab. 2015 Feb; 100 2: 490– 9.
- Kiernan TJ , O'Flynn AM , McDermott JH , Kearney P. Primary hyperparathyroidism and the cardiovascular system. Int J Cardiol. 2006 Nov 18; 113 3: E89– 92.
- Bansal N , Zelnick L , Robinson-Cohen C , Serum parathyroid hormone and 25-hydroxyvitamin D concentrations and risk of incident heart failure: the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2014 Dec 2; 3 6: e001278.
- Wannamethee SG , Welsh P , Papacosta O , Lennon L , Whincup PH , Sattar N. Elevated parathyroid hormone, but not vitamin D deficiency, is associated with increased risk of heart failure in older men with and without cardiovascular disease. Circ Heart Fail. 2014 Sep; 7 5: 732– 9.
- Witte KK , Byrom R , Gierula J , Effects of Vitamin D on Cardiac Function in Patients With Chronic HF: The VINDICATE Study. J Am Coll Cardiol. 2016 Jun 7; 67 22: 2593– 603.
- Stefenelli T , Abela C , Frank H , Cardiac abnormalities in patients with primary hyperparathyroidism: Implications for follow-up. J Clin Endocrinol Metab. 1997 Jan; 82 1: 106– 12.
- Silver J Naveh-Many T. FGF-23 and secondary hyperparathyroidism in chronic kidney disease. Nat Rev Nephrol. 2013 Nov; 9 11: 641– 9.
- Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int. 2012 Oct; 82 7: 737– 47.
- Cunningham J , Locatelli F , Rodriguez M. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol. 2011 Apr; 6 4: 913– 21.
- Zand L Kumar R. Serum parathyroid hormone concentrations and clinical outcomes in ESRD: A call for targeted clinical trials. Semin Dial. 2016 May; 29 3: 184– 8.
- Lishmanov A , Dorairajan S , Pak Y , Chaudhary K , Chockalingam A. Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease. Int Urol Nephrol. 2012 Apr; 44 2: 541– 7.
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009 Aug; 113: S1– 130.
- EVOLVE Trial Investigators, Chertow GM , Block GA , Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. N Engl J Med. 2012 Dec 27; 367 26: 2482– 94.
-
Bilezikian
JP
,
Khan
A
,
Potts
JT
Jr , Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research. J Bone Miner Res. 2011 Oct; 26 10: 2317– 37. - Shoback D. Clinical practice. Hypoparathyroidism. N Engl J Med. 2008 Jul 24; 359 4: 391– 403.
- Part 10. 1: Life-threatening electrolyte abnormalities. Circulation. 2005 Dec; 112 24 suppl: IV-121– 5.
- Bansal B , Bansal M , Bajpai P , Garewal HK. Hypocalcemic cardiomyopathy-different mechanisms in adult and pediatric cases. J Clin Endocrinol Metab. 2014 Aug; 99 8: 2627– 32.
DOI: https://doi.org/10.14797/mdcj-13-2-49 | Journal eISSN: 1947-6108
Language: English
Page range: 49 - 54
Published on: Apr 1, 2017
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
© 2017 Spandana J. Brown, Mary D. Ruppe, Laila S. Tabatabai, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.